nigella sativa
Botanicalexperimental
Nigella sativa is an annual flowering plant in the family Ranunculaceae, native to western Asia, and eastern Europe. It is naturalized over parts of Europe, northern Africa, and east to Myanmar. It is used as a spice in various food preparations, especially in Arab and Halal cuisines. — Wikipedia
Clinical trial activity
25 trials · 32 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
9
Phase 3
6
Phase 4
0
Earliest trial started Feb 1, 2006 (NCT00327054)
Timeline
Indications
Studied for
- beta-Thalassemia · Early Phase 1
- Coronavirus Infections · Phase 3
- COVID-19 · Phase 3
- Diabetes Mellitus · Phase 1/Phase 2
- Dyslipidemias · Phase 2
- Dyspepsia · Phase 2
- Gastritis · Phase 2
- Gastroesophageal Reflux · Phase 2/Phase 3
- Hypercholesterolemia · Phase 1/Phase 2
- Hypertension · Phase 3
- Metabolic Syndrome · Phase 1/Phase 2
- Obesity · Phase 1
- Primary Immunodeficiency Diseases · Phase 2/Phase 3
- SARS-CoV-2 · Phase 2
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaNigella sativa ↗
Also known as
- melanole
- nigella sativa
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07013058 | N/A | Jun 15, 2025 | Liaquat University of Medical & Health Sciences, University of Urbino "Carlo Bo" |
| NCT06901076 | N/A | Mar 12, 2024 | University of Pavia |
| NCT05770791 | Phase 1 | Jan 27, 2023 | University of Health Sciences Lahore, University of Lahore |
| NCT05494164 | N/A | Aug 7, 2022 | Cairo University |
| NCT07055763 | N/A | Mar 17, 2022 | Superior University |
| NCT04981743 | N/A | Jul 21, 2021 | Ain Shams University |
| NCT04914377 | Phase 2 | Jun 8, 2021 | Novatek Pharmaceuticals |
| NCT04989101 | N/A | Jun 5, 2021 | Hôpital Universitaire Sahloul |
| NCT04767087 | Phase 2/Phase 3 (Phase 3) | Mar 5, 2021 | Harvard University, King Edward Medical University, Sheikh Zayed Medical College, University of Veterinary and Animal Sciences, Lahore |
| NCT04914767 | Phase 1 | Mar 1, 2021 | Hôpital Universitaire Sahloul |
| NCT04553705 | Phase 2/Phase 3 (Phase 3) | Sep 20, 2020 | Beni Suef University, Maternity and Children Hospital, Makkah, Maternity and Children hospital,Mecca, Saudi Arabia, University of Arizona |
| NCT04472585 | Phase 1/Phase 2 (Phase 2) | Jul 14, 2020 | Harvard University, Mayo Hospital, Pakistan, Sheikh Zayed Medical College, University of Veterinary and Animal Sciences, Lahore |
| NCT04401202 | Phase 2 | May 21, 2020 | King Abdul-Aziz University |
| NCT04347382 | Phase 3 | Apr 15, 2020 | Harvard University, Lahore Medical and Dental college, Mayo Clinic, Sheikh Zayed Medical College, University of Veterinary and Animal Sciences, Lahore |
| NCT04686461 | N/A | Oct 20, 2019 | Bangladesh Medical University |
| NCT03925714 | Phase 3 | Apr 1, 2019 | Tanta University |
| NCT03428568 | Phase 2 | Mar 31, 2018 | King Abdullah Medical City, Saudi Arabia Army |
| NCT03643094 | N/A | Mar 14, 2018 | Natural Immune Systems Inc, New Chapter Inc |
| NCT02816957 | Early Phase 1 (Phase 1) | Jun 1, 2016 | Tanta University |
| NCT02587910 | Phase 2/Phase 3 (Phase 3) | Oct 1, 2015 | Lebanese American University |
Showing 20 of 25 trials
Page 1 / 2
Organizations
Research & Development (32)
32 organizations
Page 1 / 2